Lymphoma of the Neck: Signs and Symptoms

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies. The two major classifications are Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). Because it is a broad category of disease rather than a single, concrete disorder, head and neck lymphomas will present in a variety of ways and may have vastly different outcomes depending on location, severity, age of the patient, and other factors.

Signs and Symptoms of Lymphoma in the Neck

The most common of the symptoms of lymphoma of the neck is an enlargement of one or more lymph nodes. These swollen nodes are not usually sensitive or tender, and tend to occur in a single localized region. Hodgkin’s in the neck is almost exclusively limited to the lymph nodes, while NHL can be either nodal or extranodal. NHL also tends to occur submucosally, or deeper in the tissues of the neck than things like squamous cell carcinoma.

In addition to these primary symptoms of lymphoma of the neck, there are a number of systemic symptoms that may occur in a minority of cases. These include night sweats, weight loss, and chronically low energy levels. Also, specific symptoms will present depending on the area of primary involvement. For example, lymphoma in the tonsils will appear as a sore throat, while a tumor in the larynx may cause hoarseness or breathing problems, and one in the sinuses will cause sinusitis.

Diagnosis of Lymphoma in the Neck

To test for lymphoma of the neck, the doctor will try to obtain an excisional biopsy of one the enlarged nodes. This means that a slice of an enlarged node will be removed, intact, and will be sent to a pathologist for immediate processing. It is important to conduct the analysis quickly because that allows better differentiation between normal healthy cells and fast-growing cancer cells. Additionally, an excision is preferable to the other common option, fine needle aspiration, because it preserves the cellular structure for analysis.

Staging of Lymphoma in the Neck

A positive diagnosis will typically include an attempt to stage the disease (i.e., to determine how far it has progressed). This is more important for HL forms because each stage has a distinct treatment protocol developed for best outcomes. In addition, for both Hodgkin's disease and NHL, each stage carries a different prognosis and projected survival rates.

To determine the staging of a particular case, the doctor will examine the following factors:

  • Patient history
  • Physical exam
  • Blood tests and lab work
  • X-rays
  • Invasive biopsies

The patient will then be assigned a stage on a scale of I (single node involvement) to IV (diffuse involvement of multiple sites/organs). It is this staging that will determine next treatment steps.

Photo: Pixabay

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap